Risk assessment tools to identify women with increased risk of osteoporotic fracture: Complexity or simplicity? A systematic review. (18th July 2013)

• Record Type: Journal Article
• Authors: Rubin, Katrine Hass; Friis‐Holmberg, Teresa; Hermann, Anne Pernille; Abrahamsen, Bo; Brixen, Kim
• Is Part Of: Journal of bone and mineral research. Volume 28:Number 8(2013:Aug.)
• Page Start: 1701
• Page End: 1717
• Publication Date: 2013-07-18
• Subjects: RISK ASSESSMENT TOOLS -- SYSTEMATIC REVIEW -- SCREENING -- WOMEN -- OSTEOPOROTIC FRACTURE; Bones -- Metabolism -- Periodicals; Mineral metabolism -- Periodicals; 612.392
• DOI: 10.1002/jbmr.1956
• Languages: English
• ISSNs: 0884-0431

Abstract

ABSTRACT: A huge number of risk assessment tools have been developed. Far from all have been validated in external studies, more of them have absence of methodological and transparent evidence, and few are integrated in national guidelines. Therefore, we performed a systematic review to provide an overview of existing valid and reliable risk assessment tools for prediction of osteoporotic fractures. Additionally, we aimed to determine if the performance of each tool was sufficient for practical use, and last, to examine whether the complexity of the tools influenced their discriminative power. We searched PubMed, Embase, and Cochrane databases for papers and evaluated these with respect to methodological quality using the Quality Assessment Tool for Diagnostic Accuracy Studies (QUADAS) checklist. A total of 48 tools were identified; 20 had been externally validated, however, only six tools had been tested more than once in a population‐based setting with acceptable methodological quality. None of the tools performed consistently better than the others and simple tools (i.e., the Osteoporosis Self‐assessment Tool [OST], Osteoporosis Risk Assessment Instrument [ORAI], and Garvan Fracture Risk Calculator [Garvan]) often did as well or better than more complex tools (i.e., Simple Calculated Risk Estimation Score [SCORE], WHO Fracture Risk Assessment Tool [FRAX], and Qfracture). No studies determined the effectiveness of tools in selecting patients for therapy and thus improving fracture outcomes. High‐quality studies in randomized design with population‐based cohorts with different case mixes are needed.